Meribank Biotech Co., Ltd (TPEX:4724)

Taiwan · Delayed Price · Currency is TWD

8.93

-0.02 (-0.22%)

Sep 15, 2026, 1:42 PM CST

Meribank Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	561	1,438	2,463	2,392	-	-
Market Cap Growth	-69.87%	-41.61%	2.99%	-	-	-
Enterprise Value	401	2,450	2,542	2,260	-	-
Last Close Price	8.93	16.35	27.99	38.09	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	1.37	3.05	6.72	10.21	-	-
PB Ratio	0.47	1.14	2.02	3.56	-	-
P/TBV Ratio	1.52	3.42	7.26	3.81	-	-
P/FCF Ratio	8.97	16.80	-	-	-	-
P/OCF Ratio	8.00	16.08	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.98	5.19	6.94	9.64	-	-
EV/EBITDA Ratio	7.75	339.46	-	-	-	-
EV/FCF Ratio	6.42	28.62	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.91	0.90	0.77	0.05	0.10	0.09
Debt / EBITDA Ratio	18.93	11.04	-	-	-	-
Debt / FCF Ratio	17.24	13.17	-	-	-	-
Net Debt / Equity Ratio	0.75	0.71	0.64	-0.54	-0.34	-0.40
Net Debt / EBITDA Ratio	-23.30	124.46	-15.32	3.30	1.65	2.71
Net Debt / FCF Ratio	14.18	10.49	-2.71	10.29	3.56	7.72
Asset Turnover	0.15	0.17	0.20	0.25	0.20	0.19
Inventory Turnover	34.69	30.52	19.01	12.44	14.17	22.33
Quick Ratio	1.53	1.71	1.43	4.21	3.30	4.54
Current Ratio	1.71	1.90	1.69	4.49	3.60	4.79
Return on Equity (ROE)	-11.33%	-6.63%	-10.27%	-22.62%	-19.46%	-20.48%
Return on Assets (ROA)	-2.37%	-1.19%	-2.94%	-8.01%	-7.65%	-7.25%
Return on Capital Employed (ROCE)	-4.20%	-2.00%	-3.60%	-13.10%	-14.90%	-11.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-24.10%	-5.66%	-3.84%	-5.24%	-	-
FCF Yield	11.15%	5.95%	-11.64%	-1.48%	-	-
Buyback Yield / Dilution	-9.70%	-14.85%	-26.54%	-0.11%	-4.07%	-14.52%